Robert John
Vermogen: 50 694 $ op 31-07-2026
Vermogen: 50 694 $ op 31-07-2026
Robert John worked at Abbott Laboratories from 2008 to 2023 as General Manager-Cardiac Rhythm Management EMEA. Mr. John worked at CVRx, Inc. from 2024 to 2026 as Chief Revenue Officer.
Mr. John completed undergraduate studies at the University of North Texas and graduate studies at The University of Alabama.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CVRX, INC. 0,04% | 06-04-2026 | 9.796 ( 0,04% ) | 50 694 $ | 31-07-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CVRX, INC. | Corporate Officer/Principal | 10-08-2026 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-01-2023 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
The University of Alabama
The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau